Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitroglycerin vs Labetalol for Controlled Hypotension in Nasal Surgery
NCT03059316Phase 1Completed
- Sponsor
- Cairo University
- Start
- Jun 2016
- Primary completion
- Apr 2017
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial comparing Nitroglycerin Group with Labetalol Group (2 arms). Primary endpoints: Perfusion Index and Serum lactate. Started Jun 2016; status: completed.
02
Drugs
nitroglycerinlabetalol
Beyond the preview
Go deeper on NCT03059316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03059316.